An Evaluation of AZR-MD-001 as Treatment for Meibomian Gland Dysfunction (MGD) or Contact Lens Discomfort (CLD)
Status:
Completed
Trial end date:
2020-12-11
Target enrollment:
Participant gender:
Summary
SOVS2019-070 is a single-center study of AZR-MD-001 ointment and AZR-MD-001 vehicle in
patients with Meibomian Gland Dysfunction (MGD) or Contact Lens Discomfort (CLD).